These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3102585)

  • 1. Sustained release verapamil, a once daily preparation: objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina.
    Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
    J Am Coll Cardiol; 1987 Mar; 9(3):615-21. PubMed ID: 3102585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
    Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
    G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of bevantolol for chronic, stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Am J Cardiol; 1986 Nov; 58(12):28E-34E. PubMed ID: 2878598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of nicardipine and verapamil in the management of chronic stable angina.
    Rodrigues EA; Kohli RS; Hains AD; Lahiri A; Raftery EB
    Int J Cardiol; 1988 Mar; 18(3):357-69. PubMed ID: 3283061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
    Foale RA; Vandenburg MJ
    Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
    De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
    Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release and instant-release verapamil in treatment of angina pectoris.
    Jespersen CM; Klitgaard NA; Nielsen H; Hansen JF
    Eur J Clin Pharmacol; 1989; 36(6):625-7. PubMed ID: 2776821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
    Rodrigues EA; Lahiri A; Hughes LO; Kohli RS; Whittington JR; Raftery EB
    Am J Cardiol; 1986 Nov; 58(10):916-21. PubMed ID: 2877564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sustained-release verapamil in chronic stable angina pectoris.
    Weiner DA; Klein MD; Cutler SS
    Am J Cardiol; 1987 Feb; 59(4):215-8. PubMed ID: 3544792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A; Meshulam R; Schlesinger Z
    Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina.
    Gibbs JS; McAlpine HM; Wright C; McLenachan JM; Sparrow J; Sutton G; Dargie HJ; Fox KM
    Int J Cardiol; 1991 Jun; 31(3):281-6. PubMed ID: 1879977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
    Subramanian VB; Bowles MJ; Davies AB; Raftery EB
    Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
    Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
    Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit.
    Parodi O; Simonetti I; Michelassi C; Carpeggiani C; Biagini A; L'Abbate A; Maseri A
    Am J Cardiol; 1986 Apr; 57(11):899-906. PubMed ID: 3083668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing.
    Subramanian B; Bowles M; Lahiri A; Davies AB; Raftery EB
    Am J Cardiol; 1981 Sep; 48(3):529-35. PubMed ID: 6791487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.
    Cutler NR; Anders RJ; Jhee SS; Sramek JJ; Awan NA; Bultas J; Lahiri A; Woroszylska M
    Am J Cardiol; 1995 Jun; 75(16):1102-6. PubMed ID: 7762493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of effects of isradipine during twice daily therapy in angina pectoris.
    Thadani U; Chrysant S; Gorwit J; Giles T; Archer S; Iteld B; Singh S; Copen D; Wakeford C; Hobbs S
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):199-210. PubMed ID: 7918132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.